Ching-Fang Tsai
-
- Antifungal resistance and susceptibility 2
-
- Acute Ischemic Stroke Management 3
- Pneumonia and Respiratory Infections 2
-
- Atrial Fibrillation Management and Outcomes 4
- Antiplatelet Therapy and Cardiovascular Diseases 3
-
- Hip and Femur Fractures 3
- Pelvic and Acetabular Injuries 3
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
- Co-authors
- Solomon Chih‐Cheng ChenCheung-Ter OngErick Wan-Chun HuangYih-Yuan ChenHsin‐Yi YangMing‐Shian LinWei ChenLorraine B. Ware
- Partner nations
- TaiwanUnited States
In The Last Decade
Ching-Fang Tsai
25 papers receiving 270 citations
Peers
Comparison fields: 5 of 79
- Infectious Diseases 78
- Microbiology 25
- Epidemiology 117
- Psychiatry and Mental health 49
- Critical Care and Intensive Care Medicine 16
Countries citing papers authored by Ching-Fang Tsai
This map shows the geographic impact of Ching-Fang Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching-Fang Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching-Fang Tsai more than expected).
Fields of papers citing papers by Ching-Fang Tsai
This network shows the impact of papers produced by Ching-Fang Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching-Fang Tsai. The network helps show where Ching-Fang Tsai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ching-Fang Tsai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 11 | |
| 7 | 2022 | 5 | |
| 8 | 2021 | 3 | |
| 9 | 2021 | 2 | |
| 10 | 2021 | 4 | |
| 11 | 2020 | 5 | |
| 12 | 2020 | 3 | |
| 13 | 2020 | 12 | |
| 14 | 2018 | 10 | |
| 15 | 2017 | 23 | |
| 16 | 2017 | 45 | |
| 17 | 2016 | 9 | |
| 18 | 2016 | 20 | |
| 19 | 2015 | 43 | |
| 20 | 2015 | 19 |
About Ching-Fang Tsai
Ching-Fang Tsai is a scholar working on Internal Medicine, Epidemiology and Neurology, having authored 25 papers that have together received 276 indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Hip and Femur Fractures (3 papers), Pelvic and Acetabular Injuries (3 papers), Acute Ischemic Stroke Management (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Pneumonia and Respiratory Infections (2 papers) and Antifungal resistance and susceptibility (2 papers). The work is most often cited by research in Infectious Diseases (78 citations), Microbiology (25 citations) and Epidemiology (117 citations). Ching-Fang Tsai has collaborated with scholars based in Taiwan and United States. Frequent co-authors include Solomon Chih‐Cheng Chen, Cheung-Ter Ong, Erick Wan-Chun Huang, Yih-Yuan Chen, Hsin‐Yi Yang, Ming‐Shian Lin, Wei Chen, Lorraine B. Ware, Chuan‐Mu Chen and Yueh‐Han Hsu. Their work appears in journals such as PLoS ONE, Scientific Reports and Bone.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.